PaceMate

Private

Bradenton, FloridaHealthcare & Life Scienceshttps://pacemate.com/

Last Round

Strategic

Jul 25, 2023

Total Funding Raised

$8M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

PaceMate is a healthtech company that provides a cloud-native software and service platform for remote cardiac monitoring and data management.

Sector

Healthcare & Life Sciences

Verticals

EHR & EMR, Health IoT, Vertical SaaS, Workflow Automation, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

remote cardiac monitoringcardiac implantable electronic deviceCIEDEHR integrationcardiology softwareremote patient monitoringRPMclinical workflow automationcardiac device managementhealth techdigital healthSaaS platformhealthcare interoperabilityclinical decision supportAI-augmented healthcaremedical device data

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

PaceMate Comparables

Compare PaceMate with similar companies based on industry and business-model similarity.

PaceMate comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Murj	93%
RhythmScience Inc.	90%
Octagos Health	87%

View all Comparables

PaceMate Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Strategic	Jul 25, 2023
Series A	Mar 29, 2021
Accelerator	Sep 26, 2019

View all Funding Rounds

Key People

Founding team and executive leadership

JR Finkelmeier

Chief Executive Officer

Executive Team

Chandler Yoquelet

President And Chief Financial Officer

Executive Team

Kevin R. Campbell

Chief Scientific Officer, Board Of Directors

Executive Team

Sean Shoffstall

Chief Product Officer

Executive Team

View all key people

PaceMate Investors

Notable investors and investment history

PaceMate investors
Investor	Rounds
Dreamit Ventures	Accelerator
Lead Edge Capital	Strategic
Ballast Point Ventures	Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Apr 7, 2026
Dr. Benjamin A. Steinberg appointed as new Chief Medical Officer.
Mar 1, 2026
Integrations with Epic, Cerner, and athenahealth are now available.

View all signals

PaceMate Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

PaceMate Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about PaceMate's valuation, stock price, and market status.

Firmographic Details

HeadquartersBradenton, Florida

Employee Range219

Year Founded2015

Last FundingJul 25, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.